VANGUARD GROUP INC

Holdings History for Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

Symbol: NERV on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$1,013,156	252,029	0		$4.02	Q4 2025
30 Sep 2025	0%	0%	$534,302	252,029	-31	-0.01%	$2.12	Q3 2025
30 Jun 2025	0%	0%	$433,544	252,060	0		$1.72	Q2 2025
31 Mar 2025	0%	0%	$428,502	252,060	0		$1.70	Q1 2025
31 Dec 2024	0%	0%	$559,574	252,060	0		$2.22	Q4 2024
30 Sep 2024	0%	0%	$673,001	252,060	0		$2.67	Q3 2024
30 Jun 2024	0%	0%	$804,072	252,060	0		$3.19	Q2 2024
31 Mar 2024	0%	+0%	$650,315	252,060	+46,906	+23%	$2.58	Q1 2024
31 Dec 2023	0%	0%	$1,261,697	205,154	0		$6.15	Q4 2023
30 Sep 2023	0%	0%	$1,415,562	205,154	0		$6.90	Q3 2023
30 Jun 2023	0%	+0%	$1,875,108	205,154	+11,216	+5.8%	$9.14	Q2 2023
31 Mar 2023	0%	0%	$310,301	193,938	0		$1.60	Q1 2023
31 Dec 2022	0%	+0%	$308,362	193,938	+30,344	+19%	$1.59	Q4 2022
30 Sep 2022	0%	-0%	$1,510,000	163,594	-328,483	-67%	$9.23	Q3 2022
30 Jun 2022	0%	+0%	$1,629,000	492,077	+492,077	NEW	$3.31	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.